OBJECTIVE: C-type natriuretic peptide (CNP) is a paracrine regulatory factor of the growth plate and plays a key role in endochondral growth. Its amino-terminal propeptide (NTproCNP) is an equimolar product of CNP biosynthesis and is easily measured in plasma. Preliminary studies suggest that NTproCNP levels correlate with height velocity in sheep and children. The objectives of the study were to correlate NTproCNP levels with height velocity and to define the reference range for plasma CNP and NTproCNP across childhood. DESIGN: This was a prospective, cross-sectional, observational study of healthy children. PATIENTS: Participants were 258 healthy children between 2 months and 20 years of age. MEASUREMENTS: Anthropometrics were obtained and CNP and NTproCNP levels were determined by radioimmunoassay. RESULTS: For both sexes, CNP and NTproCNP levels were high in infancy, lower in early childhood, rising during puberty, then falling to low adult levels. Levels of NTproCNP peaked at 14·1 years in boys and 11·9 years in girls, coincident with the age of peak height velocity. Levels of NTproCNP varied with pubertal status, peaking at genital Tanner stage IV in boys and III in girls. There was a highly significant correlation between NTproCNP and height velocity. CONCLUSIONS: C-type natriuretic peptide plays an integral role in endochondral growth. We show here that CNP synthesis (as measured by NTproCNP levels in plasma) is closely related to linear growth in healthy children at all ages. We propose NTproCNP as a biomarker of linear growth.
OBJECTIVE:C-type natriuretic peptide (CNP) is a paracrine regulatory factor of the growth plate and plays a key role in endochondral growth. Its amino-terminal propeptide (NTproCNP) is an equimolar product of CNP biosynthesis and is easily measured in plasma. Preliminary studies suggest that NTproCNP levels correlate with height velocity in sheep and children. The objectives of the study were to correlate NTproCNP levels with height velocity and to define the reference range for plasma CNP and NTproCNP across childhood. DESIGN: This was a prospective, cross-sectional, observational study of healthy children. PATIENTS: Participants were 258 healthy children between 2 months and 20 years of age. MEASUREMENTS: Anthropometrics were obtained and CNP and NTproCNP levels were determined by radioimmunoassay. RESULTS: For both sexes, CNP and NTproCNP levels were high in infancy, lower in early childhood, rising during puberty, then falling to low adult levels. Levels of NTproCNP peaked at 14·1 years in boys and 11·9 years in girls, coincident with the age of peak height velocity. Levels of NTproCNP varied with pubertal status, peaking at genital Tanner stage IV in boys and III in girls. There was a highly significant correlation between NTproCNP and height velocity. CONCLUSIONS:C-type natriuretic peptide plays an integral role in endochondral growth. We show here that CNP synthesis (as measured by NTproCNP levels in plasma) is closely related to linear growth in healthy children at all ages. We propose NTproCNP as a biomarker of linear growth.
Authors: Timothy C R Prickett; Adrienne M Lynn; Graham K Barrell; Brian A Darlow; Vicky A Cameron; Eric A Espiner; A Mark Richards; Timothy G Yandle Journal: Pediatr Res Date: 2005-07-08 Impact factor: 3.756
Authors: H Tobiume; S Kanzaki; S Hida; T Ono; T Moriwake; S Yamauchi; H Tanaka; Y Seino Journal: J Clin Endocrinol Metab Date: 1997-07 Impact factor: 5.958
Authors: Naohisa Tamura; Lynda K Doolittle; Robert E Hammer; John M Shelton; James A Richardson; David L Garbers Journal: Proc Natl Acad Sci U S A Date: 2004-11-30 Impact factor: 11.205
Authors: Cynthia F Bartels; Hulya Bükülmez; Pius Padayatti; David K Rhee; Conny van Ravenswaaij-Arts; Richard M Pauli; Stefan Mundlos; David Chitayat; Ling-Yu Shih; Lihadh I Al-Gazali; Sarina Kant; Trevor Cole; Jenny Morton; Valérie Cormier-Daire; Laurence Faivre; Melissa Lees; Jeremy Kirk; Geert R Mortier; Jules Leroy; Bernhard Zabel; Chong Ae Kim; Yanick Crow; Nancy E Braverman; Focco van den Akker; Matthew L Warman Journal: Am J Hum Genet Date: 2004-05-14 Impact factor: 11.025
Authors: R Bjarnason; B Andersson; H S Kim; B Olsson; D Swolin-Eide; R Wickelgren; B Kriström; B Carlsson; K Albertsson-Wikland; L M S Carlsson Journal: J Clin Endocrinol Metab Date: 2004-10 Impact factor: 5.958
Authors: Eveline Boudin; Tjeerd R de Jong; Tim C R Prickett; Bruno Lapauw; Kaatje Toye; Viviane Van Hoof; Ilse Luyckx; Aline Verstraeten; Hugo S A Heymans; Eelco Dulfer; Lut Van Laer; Ian R Berry; Angus Dobbie; Ed Blair; Bart Loeys; Eric A Espiner; Jan M Wit; Wim Van Hul; Peter Houpt; Geert R Mortier Journal: Am J Hum Genet Date: 2018-07-19 Impact factor: 11.025
Authors: Jerid W Robinson; Jeremy R Egbert; Julia Davydova; Hannes Schmidt; Laurinda A Jaffe; Lincoln R Potter Journal: Cell Signal Date: 2017-09-28 Impact factor: 4.315
Authors: Celia L Gregson; Felicity Newell; Paul J Leo; Graeme R Clark; Lavinia Paternoster; Mhairi Marshall; Vincenzo Forgetta; John A Morris; Bing Ge; Xiao Bao; J H Duncan Bassett; Graham R Williams; Scott E Youlten; Peter I Croucher; George Davey Smith; David M Evans; John P Kemp; Matthew A Brown; Jon H Tobias; Emma L Duncan Journal: Bone Date: 2018-06-05 Impact factor: 4.398
Authors: Ryan F Coghlan; Robert C Olney; Bruce A Boston; Daniel T Coleman; Brian Johnstone; William A Horton Journal: J Clin Endocrinol Metab Date: 2021-01-01 Impact factor: 5.958
Authors: Timothy C R Prickett; Eric A Espiner; Melita Irving; Carlos Bacino; John A Phillips; Ravi Savarirayan; Jonathan R S Day; Elena Fisheleva; Kevin Larimore; Ming Liang Chan; George S Jeha Journal: Sci Rep Date: 2021-12-20 Impact factor: 4.379
Authors: Peter Lauffer; Eveline Boudin; Daniëlle C M van der Kaay; Saskia Koene; Arie van Haeringen; Vera van Tellingen; Wim Van Hul; Timothy C R Prickett; Geert Mortier; Eric A Espiner; Hermine A van Duyvenvoorde Journal: J Endocr Soc Date: 2022-02-10